Exponent’s Health Economics and Outcomes Research consultants determine the "value for money" of new medical technologies. We specialize in:
- Evaluating the impact of pharmaceuticals, medical devices, biotechnology products, and diagnostics on treatment patterns, medical care resource utilization, and health care costs
- Assessing the changes in health outcomes resulting from new medical technologies, including decreased mortality, reduced disease cases or symptoms, improved quality of life, and increased patient satisfaction
- Quantifying changes in health outcomes relative to their costs and to the costs of competing health care interventions, allowing assessment of the appropriate value for these new medical technologies
Our services include:
Economic Assessments
- Cost of illness studies
- Cost-effectiveness and cost-utility models
- Opportunity and market evaluations for product development and licensing decisions
- Value-based pricing
Clinical Trial-Based Services
- Design of economic and outcomes components for clinical trials
- Analysis and modeling of clinical trial data
- Clinical trial outcomes data collection /data management
Medical Care Data Analyses
- Managed care claims data analysis
- Analysis of national survey data (e.g., NAMCS)
Post-Approval/Phase IV Studies
- Managed care (AMCP) clinical and economic dossier preparation
- Formulary impact models
- Naturalistic prospective studies
- Patient preference evaluations
- Health-related quality of life (HRQoL) assessments
- Post-marketing safety assessments
Real-World Outcomes Applications
- Physician decision-making studies
- Work site-based studies
- Activity-based costing (time and motion studies)
- User-friendly interactive computer models